The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
A transpacific, mid-market private equity investor focused on companies and industries at a strategic inflection point — driving transformative growth through technology, new business models, and unfettered access to global markets.
Private equityceladonpartners.comSince 2025-03-18
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
RegCell RegCell develops therapies based on regulatory T cells (Treg) to treat autoimmune diseases. | Seed Developing, 4 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | n/a | 2025-03-18 | [ PART ] |